About
Sarah Bhagat, with a Ph.D. in Neuroscience from Yale and psychiatry postdoc at Stanford, is a hands-on, board-active partner focused on scientifically ambitious therapeutics like gene therapy, immuno-oncology and CNS conditions.
Invests in
BiotechHealthtechMedical Devices
Colleagues at Sofinnova Ventures
Alex Chan
Controller, Private Equity at Sofinnova Ventures
Alex Dulnev
IT Manager at Sofinnova Ventures
Amanda Phillips
Executive Assistant at Sofinnova Ventures
Anastasia Voevodin
Analyst, Public Equity at Sofinnova Ventures
Aneal Tenjarla
Partner, Associate Portfolio Manager, Public Equity at Sofinnova Ventures
Calvin Sternick
Analyst, Public Equity at Sofinnova Ventures
Chris Carpenter
Executive Partner, Private Equity at Sofinnova Ventures
David Kabakoff
Executive Partner, Private Equity at Sofinnova Ventures